Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.98 HKD | +2.80% | -2.38% | +4.49% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
ETFs positioned on Ocumension Therapeutics
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.59% | 4 M€ | -27.92% | ||
0.00% | 34 M€ | +3.43% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.49% | 603M | |
+30.10% | 684B | |
+30.34% | 568B | |
-3.88% | 361B | |
+18.24% | 329B | |
+4.17% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.85% | 166B |
- Stock Market
- Equities
- 1477 Stock
- Funds and ETFs Ocumension Therapeutics